Glycobiology Market: 14.23% Y-O-Y Growth Rate in 2022 | By Application (drug discovery and development, disease diagnostics, and others) and Geography – Global Forecast to 2026

The Glycobiology Market Share is expected to increase by USD 1.13 billion from 2021 to 2026, at an accelerated CAGR of 14.84%, according to the recent market study by Technavio.

Segmentation by Application (In-Scope/Out-of-Scope)

In-Scope:Drug discovery and development:

The glycobiology market share growth by the drug discovery and development segment will be significant during the forecast period. The advancements in the field of glycobiology such as mass spectromey will drive the growth of the market in focus through this segment in the coming years.Out-of-Scope:Disease diagnosticsOthers

To gain further insights on the market contribution of various segments Request for a FREE sample


Segmentation- The report extensively covers market segmentation by Application (drug discovery and development, disease diagnostics, and others) and Geography (North America, Europe, Asia, and ROW)Key Companies- Agilent Technologies Inc., Asparia Glycomics S.L., Bio Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, Glycosensors and Diagnostics LLC, ICE S.p.A., Ludger Ltd, Merck KGaA, New England Biolabs Inc., Plexera LLC, RayBiotech Life Inc., Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and Z Biotech LLC among othersDriver- Growing prevalence of cancer to drive the marketChallenge- Low availability of skilled professionals to hamper the market growth

Vendor Insights-

The glycobiology market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

New England Biolabs Inc.- The company offers a wide range of glycobiology products such as Bacteroides Heparinase, Endo S, Rapid PNGase F. It is a privately held company headquartered in the US. It is a global company, with limited information regarding its financials and limited information regarding its employee strength is available. Its revenue from the global glycobiology market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company.

Find additional highlights on the vendors and their product offerings. Download Free Sample Report

Learn More about Key Driver & Challenge of the Market-
Glycobiology Market Driver:Growing prevalence of cancer:
Cancer has become the second leading cause of death worldwide. In 2020, there were 19.3 million new cancer cases and 10 million cancer-related deaths worldwide. Cancers such as melanoma, lung cancer, breast cancer, uterine cancer, thyroid cancer, and bladder cancer mainly contribute to the increased number of new cancer cases in the US. For instance, as per the centers for disease and prevention (CDC), the number of cancers caused due to overweight, except breast and colorectal cancers, is expected to increase to 30%-40% in 2020. Cancer can occur in any individual irrespective of age or gender. In the US, 89,500 adolescents and young adults ages 15-39 years were diagnosed with cancer, and 9,270 died of the condition in 2020. The rapidly rising incidence of cancer worldwide is a significant factor driving the global glycobiology market.Glycobiology Market Challenge:Low availability of skilled professionals:
One of the key challenges to the global glycobiology market growth is the low availability of skilled professionals to conduct extensive research and conduct the process, which is risky and cost-and time-consuming at the same time. Laboratory professionals are skilled and certified professionals who are trained in the theoretical and practical aspects of glycobiology. Glycobiology professionals play different roles in the process, such as staff technologists, research technologists, supervisors, managers, or educators. There is a shortage of trained professionals who can handle technologically advanced glycobiology products. Such factors are expected to negatively impact the growth of the global glycobiology market during the forecast period.
Didn’t Find What You Were Looking For? Customize Report-
Don’t miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now!
Here are Some Similar Topics-
Microfluidics Technology Market by Material and Geography – Forecast and Analysis 2021-2025: The microfluidics technology market share is expected to increase by USD 10.45 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 18.36%. To get more exclusive research insights: Download Free Sample Report
Molecular Biology Enzymes, Kits, and Reagents Market by End-user and Geography – Forecast and Analysis 2021-2025: The molecular biology enzymes, kits, and reagents market share is expected to increase by USD 13.09 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 14.61%. To get more exclusive research insights: Download Free Sample Report

This article was shared with Prittle Prattle News as a Press Release.

Must Read –Vyaapar Jagat Fempreneur

Follow Us: Facebook Instagram | Twitter YouTube | LinkedIn Pinterest Tumblr

Related Posts

1 of 428